References

1. Chobanian, A. V; Bakris, G. L.; Black, H. R.; Cushman, W C.; Green, L. A.; Izzo, J. L., Jr.; Jones, D. W; Materson, B. J.; Oparil, S.; Wright, J. T, Jr. et al. J. Hypertens. 2003, 42, 1206-1252.

2. Lloyd-Jones, D. M.; Evans, J. C.; Larson, M. G.; Levy, D. Hypertension 2002, 40, 640-646.

3. Lloyd-Jones, D. M.; Evans, J. C.; Levy, D. JAMA 2005, 294, 466-472.

4. Valderrabano, F; Gomez-Campdera, F; Jones, E. H. Kidney Int. 1998, 68, S60-S66.

5. Lloyd, A.; Schmieder, C.; Marchant, N. Pharmacoeconomics 2003, 21, 33-41.

6. Banegas Banegas, J. R. An. Real Acad. Nac. Med. 2002, 119, 143-152.

7. Takahashi, N.; Smithies, O. Trends Genet. 2004, 20, 136-145.

8. Timberlake, D. S.; O'Connor, D. T.; Parmer, R. Curr. Opin. Nephrol. Hypertens. 2001, 10, 71-79.

9. Saeed, M. M.; Saboohi, K.; Osman, A. S.; Bokhari, A. M.; Frossard, P. M. J. Hum. Hypertens. 2003, 17, 719-723.

10. Baudin, B. Pharmacogenomics 2002, 3, 65-73.

11. Hannila-Handelberg, T; Kontula, K.; Tikkanen, I.; Tikkanen, T; Fyhrquist, F; Helin, K.; Fodstad, H.; Piippo, K.; Miettinen, H. E.; Virtamo, J. et al. BMC Med. Genet. 2005, 6, 4.

13. Nesbitt, S. D. Curr. Cardiol. Rep. 2004, 6, 416-420.

14. Wiesel, P; Mazzolai, L.; Nussberger, J.; Pedrazzini, T Hypertension 1997, 29, 1025-1030.

15. Cervenka, L.; Horacek, V; Vaneckova, I.; Hubacek, J. A.; Oliverio, M. I.; Coffman, T M.; Navar, L. G. Hypertension 2002, 40, 735-741.

16. van den Meiracker, A. H. J. Hypertens. 2002, 20, 587-589.

17. Iglarz, M.; Touyz, R. M.; Viel, E. C.; Paradis, P; Amiri, F; Diep, Q. N.; Schiffrin, E. L. Hypertension 2003, 42, 737-743.

18. Rossi, G. P; Colonna, S.; Belloni, A. S.; Savoia, C.; Albertin, G.; Nussdorfer, G. G.; Hagiwara, H.; Rubattu, S.; Volpe, M. J. Hypertens. 2003, 21, 105-113.

19. Manger, W M.; Simchon, S.; Stier, C. T, Jr.; Loscalzo, J.; Jan, K. M.; Jan, R.; Haddy, F J. Hypertension 2003, 21, 2305-2313.

20. Lighthall, G. K.; Hamilton, B. P; Hamlyn, J. M. J. Hypertens. 2004, 22, 1487-1494.

21. Ferrari, P; Torielli, L.; Ferrandi, M.; Padoani, G.; Duzzi, L.; Florio, M.; Conti, F; Melloni, P; Vesci, L.; Corsico, N. et al. J. Pharmacol. Exp. Ther. 1998, 285, 83-94.

22. Dominiczak, A. F; Negrin, D. C.; Clark, J. S.; Brosnan, M. J.; McBride, M. W; Alexander, M. Y Hypertension 2000, 35, 164.

23. Stier, C. T, Jr. Cardiovasc. Drug Rev. 2003, 21, 169-184.

24. Croom, K. F; Perry, C. M. Am. J. Cardiovasc. Drugs 2005, 5, 51-69.

26. Cheng, J.; Kamiya, K.; Kodama, I. Cardiovasc. Drug Rev. 2001, 19, 152-171.

27. Kuroedov, A.; Cosentino, F; Lüscher, T F Cardiovasc. Drug Rev. 2004, 22, 155-168.

28. Hernandez Hernandez, R.; Angeli-Greaves, M.; Carvajal, A. R.; Guerrero Pajuelo, J.; Armas Padilla, M. C.; Armas-Hernandez, M. J. Am. J. Hypertens. 1996, 9, 437-444.

30. Barzilay, J. I.; Davis, B. R.; Bettencourt, J.; Margolis, K. L.; Goff, D. C., Jr.; Black, H.; Habib, G.; Ellsworth, A.; Force, R. W; Wiegmann, T et al. J. Clin. Hypertens. 2004, 6, 116-125.

31. Dutkiewicz, S. Int. Urol. Nephrol. 2004, 36, 169-173.

32. Xu, K.; Wang, X.; Ling, P M.; Tsao, S. W; Wong, Y C. Oncol. Rep. 2003, 10, 1555-1560.

33. Vater, W; Kroneberg, G.; Hoffmeister, F; Kaller, H.; Meng, K.; Oberdorf, A.; Puls, W; Schloßmann, K.; Stolpel, K. Arzneimittelforschung 1972, 22, 1-14.

34. Furberg, C. D.; Psaty, B. M.; Meyer, J. V Circulation 1995, 92, 1326-1331.

35. Epstein, M. Safety of Calcium Antagonists as Antihypertensive Agents: An Update. In Calcium Antagonists in Clinical Medicine, 3rd ed; Epstein, M., Ed.; Hanley & Belfus: Philadelphia, PA, 2002, pp 807-832.

36. Ad Hoc Subcommittee of the Liaison Committee of the World Health Organization and the International Society of Hypertension. J. Hypertens. 1997, 15, 105-115.

37. Meredith, P A.; Elliott, H. L. J. Hypertens. 2004, 22, 1641-1648.

38. Piepho, R. W Am. J. Health-System Pharmacy 2000, 57, S3-S7.

39. Powell, J. R.; Reeves, R. A.; Marino, M. R.; Cazaubon, C.; Nusato, D. Cardiovasc. Drug Rev. 1998, 16, 169-194.

40. Wienen, W; Entzeroth, M.; van Meel, J. C. A.; Stangier, J.; Busch, U.; Schmid, J.; Lehmann, H.; Matzek, K.; Kempthorne-Rawson, G. V; Hauel, N. H. Cardiovasc. Drug Rev. 2000, 18, 127-156.

41. Gleiter, C. H.; Jagle, C.; Gresser, U.; Mörike, K. Cardiovasc. Drug Rev. 2004, 22, 263-284.

42. Stanton, A.; Jensen, C.; Nussberger, J.; O'Brien, E. Hypertension 2003, 42, 1137-1143.

43. Trippodo, N. C.; Robl, J. A.; Asaad, M. M.; Fox, M.; Panchal, B. C.; Schaeffer, T R. Am. J. Hypertens. 1998, 11, 363-372.

44. Zanchi, A.; Maillard, M.; Burnier, M. Curr. Hypertens. Rep. 2003, 5, 346-352.

45. Lilienfeld, D. E.; Rubin, L. J. Chest 2000, 117, 796-800.

46. Rashid, A.; Lahrman, S.; Romano, P; Frishman, W; Dobkin, J.; Reichel, J. Heart Dis. 2000, 2, 422-430.

47. Cohen, H.; Chahine, C.; Hui, A.; Mukherji, R. Am. J. Health-System Pharmacy 2004, 61, 1107-1119.

48 . Lin, H . C . ; Yang, Y Y ; Hou, M . C . ; Huang, Y T ; Lee, F Y ; Lee, S . D . Am. J. Gastroenterol. 2004, 99, 1953-1958 .

49. Jamerson, K. A.; Bakris, G. L.; Wun, C. C.; Dahlof, B.; Lefkowitz, M.; Manfreda, S.; Pitt, B.; Velazquez, E. J.; Weber, M. A. Am. J. Hypertens. 2004, 17, 793-801.

50. McKay, M. J.; Gaballa, M. A. Cardiovasc. Drug Rev. 2001, 19, 245-262.

51. Pachori, A. S.; Huentelman, M. J.; Francis, S. C.; Gelband, C. H.; Katovich, M. J.; Raizada, M. K. Hypertension 2001, 37, 357-364.

52. Tomita, N.; Morishita, R. Curr. Pharm. Design. 2004, 10, 797-803.

Biography

Alexander Scriabine received his MS degree in pharmacology from Cornell University and an MD degree from the University of Mainz, in Germany. Dr Scriabine spent 36 years of his professional life in that pharmaceutical industry, rising from a bench pharmacologist to Research Manager at Pfizer and from Research Fellow to Executive Director at Merck, Sharp, and Dohme. For 14 years, Dr Scriabine was employed by Miles (now Bayer Corporation) in West Haven, CT. Dr Scriabine was also an Assistant Professor and subsequently an Associate Professor of Pharmacology at the University of Pennsylvania Medical School. He is currently the editor of Cardiovascular Drug Reviews and CNS Drug Reviews, a consultant to industry and lecturer at Yale University School of Medicine. He has published over 150 research articles, review articles, and edited 15 books. He has contributed chapters to many books, including Cardiovascular Pharmacology, Pharmacology of Antihypertensive Drugs, Calcium Antagonists in Clinical Medicine, Pharmaceutical Innovation, and Neuroprotection in CNS Diseases. He is best known for his contributions to the pharmacology of antihypertensive drugs, including a-, ß-adrenoceptor and calcium channel antagonists and diuretics as well as neuroprotective drugs. He also participated in the discovery and the development of prazosin, polythiazide, timolol, nimodipine, nitrendipine, and many other drugs. He resides in Guilford, CT, USA.

© 2007 Elsevier Ltd. All Rights Reserved Comprehensive Medicinal Chemistry II

No part of this publication may be reproduced, stored in any retrieval system or transmitted ISBN (set): 0-08-044513-6 in any form by any means electronic, electrostatic, magnetic tape, mechanical, photocopying, recording or otherwise, without permission in writing from the publishers ISBN (Volume 6) 0-08-044519-5; pp. 705-728

Blood Pressure Health

Blood Pressure Health

Your heart pumps blood throughout your body using a network of tubing called arteries and capillaries which return the blood back to your heart via your veins. Blood pressure is the force of the blood pushing against the walls of your arteries as your heart beats.Learn more...

Get My Free Ebook


Post a comment